News & Press Releases
Filter by:
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Mintz Advises Premier Wealth Advisor Breed’s Hill Capital on Acquisition by Corient
September 12, 2025
Mintz represented Breed’s Hill Capital, a multi-family office overseeing approximately $3.5 billion in assets, in its acquisition by Corient, one of the nation’s leading wealth management firms. The transaction enhances Corient’s footprint in New England and advances its ability to deliver personalized fiduciary wealth management services across the region.
Mintz Advises Andromeda Robotics on Venture-Led Series A Financing
September 11, 2025
Mintz advised Andromeda Robotics on its AU$23 million Series A capital raise, led by San Francisco’s Forerunner Ventures.
Three Mintz Attorneys Recognized in Lawdragon’s 2025 500 Leading Global Real Estate Lawyers
September 11, 2025
Mintz members Daniel Guggenheim, Rebecca Lee, and Jeffrey Moerdler have been recognized by Lawdragon in its 2025 500 Leading Global Real Estate Lawyers list. The three attorneys were also recognized in last year’s inaugural edition of the list.
Mintz Advises the Underwriters in Ondas Holdings’ $230 Million Underwritten Offering
September 11, 2025
Mintz advised the underwriters in connection with the $230 million underwritten offering by Ondas Holdings Inc. of 46,000,000 shares of its common stock, which includes 6,000,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.
Mintz Recognized in LMG’s “Life Sciences Americas Awards” 2025
September 08, 2025
Mintz received a pair of awards at LMG’s 2025 “Life Sciences Americas Awards” which recognize the region’s “most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months.”
